Key Takeaways
- • EQT's revised offer of £8.93bn (58 pence per share) has been formally rejected by Intertek's board, marking the third rejection of the Swedish private equity firm's takeover proposal following earlier bids at 54 pence and 51.5 pence per share.
- • Intertek's board cited significant undervaluation and execution uncertainty as primary reasons for rejection, arguing the bid fails to reflect the company's long-term strategic prospects and presents material deal completion risk.
- • A successful transaction would represent the second-largest UK private equity buyout on record, surpassed only by KKR's £11.1bn Boots acquisition in 2007, according to Mergermarket data.
- • The deal dynamics underscore divergent valuations between EQT and Intertek management, with the buyer attempting to bridge the gap through three successive price increases totaling approximately 12% from initial approach to current offer.
Summary
Intertek, the UK-listed testing, inspection, and certification group, has formally rejected EQT's improved takeover proposal valued at £8.93bn ($12.1bn), or 58 pence per share. The rejection marks the third consecutive rebuff of the Swedish private equity firm's acquisition attempt, following earlier proposals submitted at 54 pence and 51.5 pence per share, both of which were also declined by the company's board.
In its rejection, Intertek's board stated that EQT's latest offer significantly undervalues the business and fails to adequately reflect the company's long-term prospects and strategic value. The board additionally cited considerable execution uncertainty and deal completion risk as material concerns, suggesting that beyond valuation disparities, the firm has concerns regarding whether the transaction would successfully close.
EQT's progression of offers—from 51.5 pence to 54 pence to 58 pence per share—indicates the buyer's effort to narrow the valuation gap with Intertek management. However, even the enhanced bid has proved insufficient to satisfy the board's minimum expectations for shareholder value and transaction certainty.
The scale of this potential acquisition underscores Intertek's significance within the UK market. Should a deal eventually proceed at or near current pricing, the transaction would rank as the second-largest private equity buyout in UK history, according to Mergermarket data. Only KKR's £11.1bn acquisition of pharmacy chain Boots in 2007 would exceed it. This positioning reflects both Intertek's substantial enterprise value and the stakes involved in the ongoing negotiation.
The continued impasse between EQT and Intertek's board leaves the company's strategic direction uncertain, with the private equity buyer facing escalating pressure to either significantly increase its offer or potentially withdraw from the pursuit.
In its rejection, Intertek's board stated that EQT's latest offer significantly undervalues the business and fails to adequately reflect the company's long-term prospects and strategic value. The board additionally cited considerable execution uncertainty and deal completion risk as material concerns, suggesting that beyond valuation disparities, the firm has concerns regarding whether the transaction would successfully close.
EQT's progression of offers—from 51.5 pence to 54 pence to 58 pence per share—indicates the buyer's effort to narrow the valuation gap with Intertek management. However, even the enhanced bid has proved insufficient to satisfy the board's minimum expectations for shareholder value and transaction certainty.
The scale of this potential acquisition underscores Intertek's significance within the UK market. Should a deal eventually proceed at or near current pricing, the transaction would rank as the second-largest private equity buyout in UK history, according to Mergermarket data. Only KKR's £11.1bn acquisition of pharmacy chain Boots in 2007 would exceed it. This positioning reflects both Intertek's substantial enterprise value and the stakes involved in the ongoing negotiation.
The continued impasse between EQT and Intertek's board leaves the company's strategic direction uncertain, with the private equity buyer facing escalating pressure to either significantly increase its offer or potentially withdraw from the pursuit.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.